Veracyte Announces Second Quarter 2026 Financial Results
Veracyte reported Q2 total revenue of $150.3 million, up 15% year-over-year, with testing revenue growing 19% to $145.7 million. GAAP net income was $25.5 million, representing a 17% margin, while adjusted EBITDA increased 23% to $44.0 million. The company raised its full-year 2026 revenue guidance to $590 million to $596 million (14-15% growth), citing strength in its core Decipher and Afirma franchises. Growth was driven by a 20% increase in Decipher revenue to $91.9 million and an 18% rise in Afirma revenue to $51.2 million.
Key figures
- Eps
- 0.31
- Revenue
- 150300000
- Guidance
- 2026 total revenue $590M-$596M (14-15% growth), raised from $582M-$592M
- Revenue Yoy
- 15%
- Non gaap eps
- 0.54
- Afirma revenue
- 51200000
- Adjusted ebitda
- 44000000
- Gaap net income
- 25500000
- Testing revenue
- 145700000
- Decipher revenue
- 91900000
- Adj ebitda margin
- 29.2%
- Testing revenue yoy
- 19%
- Cash equivalents and investments
- 485200000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.